Drug Resistance and Quercetin in Cancer Treatment
Author Information
Author(s): G Sliutzl, J Karlseder, C Tempfer, L Orel, G Holzer, MM Simon
Primary Institution: University of Vienna, Medical School
Hypothesis
Does hsp70 overexpression confer resistance to topotecan and gemcitabine, and can quercetin sensitize these cells to chemotherapy?
Conclusion
Hsp70 overexpression provides resistance to topotecan and gemcitabine, but quercetin can sensitize these resistant cells to chemotherapy.
Supporting Evidence
- Hsp70 overexpression was shown to significantly increase cell survival after treatment with topotecan and gemcitabine.
- Quercetin treatment resulted in a marked decrease in hsp70 levels and increased sensitivity to chemotherapy.
- Cells overexpressing hsp70 were able to restart proliferation after drug treatment, while control cells could not.
Takeaway
Some cancer cells can survive treatments that usually kill them because they have a special protein called hsp70. A natural substance called quercetin can help make these cells more sensitive to the drugs.
Methodology
The study used stably transfected fibrosarcoma cell lines to assess the impact of hsp70 overexpression on drug resistance and the sensitizing effect of quercetin.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Want to read the original?
Access the complete publication on the publisher's website